Brief: Jacobson Pharma Corporation Posts FY Revenue Of HKD1,467.8 Mln
20/06/2024 14:01
Jun 20 (Reuters) - Jacobson Pharma Corporation FY revenue HKD 1,467.8 million. * FY revenue continuing operations HKD 1,467.8 million * FY adjusted EBITDA HKD 453.1 million * FY net income attributable HKD 267 million
Recent news on Jacobson Pharma
See all newsBrief: Jacobson Pharma Corp Says Chai Herbal To Buy 124,500 Shares Of Li Chung Shing Tong (Holdings)
Brief: Jacobson Pharma Corp's Unit Accepts Tender For Tai Po Factory Works At Hk$607.2 Million
Brief: Jacobson Pharma Corp Posts H1 Revenue Of HKD 766.6 Million
Brief: Jacobson Pharma Corporation Posts FY Net Income Attributable HKD 300.8 Million
Brief: Jacobson Pharma Corporation To Subscribe Shares In Tycoon Group